Results 221 to 230 of about 18,162 (243)

Raltegravir

Reactions Weekly, 2021
openaire   +2 more sources

Raltegravir

Reactions Weekly, 2009
openaire   +2 more sources

Raltegravir

Reactions Weekly, 2016
  +5 more sources

Raltegravir

Reactions Weekly, 2013
openaire   +2 more sources

Raltegravir

Reactions Weekly, 2018
openaire   +2 more sources

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Lancet, The, 2009
Jeffrey L Lennox, Adriano Lazzarin, José Valdez Ramalho Madruga   +2 more
exaly  

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Lancet, The, 2013
Carlo Torti, Chloe Orkin, Mark Bloch
exaly  

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Lancet, The, 2010
Joseph J Eron, Benjamin Young, Michael D Miller   +2 more
exaly  

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Lancet, The, 2013
Andrey Shuldyakov, Carlos Brites, Jaime F Andrade-Villanueva   +2 more
exaly  

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

New England Journal of Medicine, 2008
Mauro Schechter, Jeffrey L Lennox, Jose M Gatell   +2 more
exaly